[HTML][HTML] A clinical insight on new discovered molecules and repurposed drugs for the treatment of COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began churning out
incredulous terror in December 2019. Within several months from its first detection in …
incredulous terror in December 2019. Within several months from its first detection in …
[PDF][PDF] A Green Eco-friendly Analytical Method Development, Validation, and Stress Degradation Studies of Favipiravir in Bulk and Different Tablet Dosages Form by …
S Chakraborty, S Mondal - International Journal of Pharmaceutical …, 2023 - researchgate.net
Favipiravir is an antiviral drug with significant and widespread antiviral action. Favipiravir
was crucial in the contest against the COVID-19 pandemic because of how well it treated the …
was crucial in the contest against the COVID-19 pandemic because of how well it treated the …
[HTML][HTML] Development and validation of HPLC-UV method for the determination of favipiravir in human plasma
TN Komarov, PK Karnakova… - Drug development & …, 2022 - pharmjournal.ru
Abstract Introduction. Coronavirus disease (COVID-19) is an acute infectious disease
caused by SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2) …
caused by SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2) …
[HTML][HTML] Small-molecule metabolites in SARS-CoV-2 treatment: a comprehensive review
R Alipoor, R Ranjbar - Biological Chemistry, 2023 - degruyter.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has quickly spread all
over the world. In this respect, traditional medicinal chemistry, repurposing, and …
over the world. In this respect, traditional medicinal chemistry, repurposing, and …
Highly selective and sensitive potentiometric determination of favipiravir in COVID-19 antiviral drug formulations
In this study, a novel all-solid-state electrochemical sensor based on favipiravir-
tetraphenylborate (FAV-TPB) electroactive material was developed and reported for FAV's …
tetraphenylborate (FAV-TPB) electroactive material was developed and reported for FAV's …
Изучение кишечной проницаемости на модели Caco-2 производного фенилтетрагидрохинолиндиона с TRPA₁-антагонистической активностью
НВ Пятигорская, АД Кравченко - Разработка и регистрация …, 2022 - pharmjournal.ru
Аннотация Введение. Данная работа посвящена изучению кишечной проницаемости
инновационного биологически активного вещества–7-(2-хлорфенил)-4-(4-метил-1, 3 …
инновационного биологически активного вещества–7-(2-хлорфенил)-4-(4-метил-1, 3 …
Разработка и валидация методики определения фавипиравира в плазме крови человека методом ВЭЖХ-УФ
ТН Комаров, ПК Карнакова, ОА Арчакова… - Разработка и …, 2022 - pharmjournal.ru
Аннотация Введение. Новая коронавирусная инфекция COVID-19 (Coronavirus Disease
2019)–это острое инфекционное заболевание, вызываемое вирусом SARS-CoV-2 …
2019)–это острое инфекционное заболевание, вызываемое вирусом SARS-CoV-2 …
Computational Study of the Correlation of in-vitro Antiviral Activities Against SARS-CoV-2 with Different Theoretical Descriptors
MA Diaz Donis, DS Coll, A Sierraalta… - Physical Chemistry …, 2022 - physchemres.org
The electrostatic potential (V (r)), the average local ionization energy (I (r)), the relative
hardness (ηrel), the electron affinity (EA), the ionization potential (IP), the electronegativity …
hardness (ηrel), the electron affinity (EA), the ionization potential (IP), the electronegativity …
РАЗРАБОТКА И РЕГИСТРАЦИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
ТН Комаров, ПК Карнакова, ОА Арчакова… - РАЗРАБОТКА И …, 2022 - elibrary.ru
Введение. Новая коронавирусная инфекция COVID-19 (Coronavirus Disease 2019)-это
острое инфекционное заболевание, вызываемое вирусом SARS-CoV-2 (severe acute …
острое инфекционное заболевание, вызываемое вирусом SARS-CoV-2 (severe acute …